HBV Genotype B/C and Response to Lamivudine Therapy: A Systematic Review

Table 1

Characteristics of HBV DNA studies included in the meta-analysis.

Author	Year	𝑁	Age (years)	Gender (M%)	Genotype (B/C)	Severity of liver disease	HBVDNA (log copies/mL)
Lu et al. [17]	2008	71	32±9.0	83	10/61	CHB	7.7±0.8
Li et al. [18]	2011	179	35.4±10.3	80	113/66	CHB	9.4±1.3
Orito et al. [19]	2006	67	41.5±12.2	67	33/34	CHB	10.7±1.1
Zou et al. [11]	2007	41	32.1±9.6	85	6/35	CHB	5.8±1.2
Song et al. [12]	2005	413	—	—	53/360	CHB	—
Bonino et al. [20]	2007	106	37.9±10.6	82	49/57	CHB	8.9±1.1
Lau et al. [21]	2005	235	31.6±9.7	91	73/162	CHB	10.1±2.0
Kobayashi et al. [15]	2006	487	45.1±13.1	86	38/449	CHB	7.2±0.0
Suzuki et al. [22]	2003	224	46±12.1	—	21/203	CHB	9.1±1.6
Zhou et al. [23]	2003	37	—	—	16/21	CHB	8.3±1.2

𝑁: numbers of patients; CHB: chronic hepatitis B.